Pages that link to "Q39795545"
Jump to navigation
Jump to search
The following pages link to Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells (Q39795545):
Displaying 50 items.
- The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis (Q33791263) (← links)
- How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex (Q33797139) (← links)
- Control of apoptosis by Rel/NF-kappaB transcription factors (Q33797163) (← links)
- The molecular and cellular origins of Hodgkin's disease (Q33818404) (← links)
- Paediatric Hodgkin's disease (Q33837294) (← links)
- Oncogenic activation of NF-kappaB. (Q33849388) (← links)
- Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. (Q33863064) (← links)
- The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance (Q33866655) (← links)
- Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway (Q33872322) (← links)
- NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma (Q33878632) (← links)
- Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies (Q33886267) (← links)
- Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies (Q33889168) (← links)
- Kinase inhibitors in cancer therapy: a look ahead (Q33897202) (← links)
- NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. (Q33959017) (← links)
- The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). (Q33962748) (← links)
- Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells (Q33964689) (← links)
- Nuclear factor-kappa B, cancer, and apoptosis (Q34047210) (← links)
- Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia (Q34048276) (← links)
- Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies. (Q34054886) (← links)
- NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment (Q34088808) (← links)
- Epstein-Barr virus and Hodgkin's disease (Q34107897) (← links)
- An NAD(P)H oxidase regulates growth and transcription in melanoma cells (Q34127326) (← links)
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. (Q34131747) (← links)
- Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells. (Q34182208) (← links)
- Senescence, apoptosis and therapy--cutting the lifelines of cancer. (Q34187808) (← links)
- The Reed-Sternberg cell in classical Hodgkin's disease (Q34199578) (← links)
- Epstein-Barr virus and oncogenesis: from latent genes to tumours (Q34221194) (← links)
- Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment (Q34235750) (← links)
- Endostatin's antiangiogenic signaling network (Q34306081) (← links)
- The biology of human lymphoid malignancies revealed by gene expression profiling. (Q34313320) (← links)
- Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation (Q34338138) (← links)
- Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy (Q34380190) (← links)
- Ubiquitin proteasome pathway: implications and advances in cancer therapy (Q34446282) (← links)
- Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production (Q34519416) (← links)
- Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes (Q34520636) (← links)
- EBV in Hodgkin Lymphoma (Q34549468) (← links)
- Molecular biology of Hodgkin's lymphoma (Q34554743) (← links)
- NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs) (Q34560200) (← links)
- The role of Epstein-Barr virus in cancer (Q34574840) (← links)
- Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways (Q34575948) (← links)
- Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions (Q34576340) (← links)
- Mutations in the NF-kappaB signaling pathway: implications for human disease (Q34577553) (← links)
- Unique molecular and cellular features of acute myelogenous leukemia stem cells (Q34605272) (← links)
- Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis (Q34611577) (← links)
- Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice (Q34616590) (← links)
- A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma (Q34617756) (← links)
- The molecular pathogenesis of Hodgkin lymphoma. (Q34626576) (← links)
- Hodgkin lymphoma (Q34643277) (← links)
- Epstein-Barr virus-associated lymphomas. (Q34651670) (← links)
- The role of chalcones in suppression of NF-κB-mediated inflammation and cancer (Q34682265) (← links)